Forty years after the emergence of HDV, the first anti-HDV therapeutic has been approved by the EMA, indicating the dawn of a new era for this difficult to treat disease
In this phase 4 non-inferiority trial, researchers compared the effects of short course vs standard course therapy with sofosbuvir-velpatasvir for the treatment of patients with hepatitis C virus.
Investigators assessed the safety profile and antiviral activity of the agent RO7049389 for the treatment of chronic hepatitis B virus infection.
The phase 2 trial was evaluating the effects of ABI-H2158 in 88 treatment-naïve patients with HBeAg positive or HBeAg negative chronic hepatitis B infection without cirrhosis.
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Investigators described a syndrome of cholangiopathy in patients recovering from severe COVID-19 with abnormal liver tests and bile duct injury.
Black recipients of liver transplants (LTs) have lower survival compared with Whites or Hispanics.
Investigators assessed the outcomes of SARS-CoV-2 positivity in patients with chronic liver diseases and cirrhosis.
Investigators assessed the effects of an exercise program with telemonitoring-based supervision on liver inflammation and risk for metabolic-associated fatty liver disease.
Investigators aimed to describe trends in hospitalization among patients with comorbid chronic liver diseases and substance use disorders.
Investigators analyzed the current evidence for treatment of hepatocellular carcinoma and what factors might impact response to therapies.
Investigators assessed the relationship between abnormal liver function tests and severe COVID-19 disease course.
VTX-801 is an investigational, novel rAAV-based gene therapy that delivers a shortened version of the ATP7B transgene.
Investigators assessed the cardiac-specific mortality rate among patients with major GI cancers, as well as the relationship between radiation and chemotherapy with survival outcomes.
Investigators reported on the hepatitis C virus cascade of care throughout the first few years of a treatment-as-prevention program initiated in Iceland.
Early arrival at the site after the attack on Sept. 11, 2001, is associated with an increased risk for hepatic steatosis among World Trade Center responders.
The new vial sizes are currently in stock and commercially available in the US.
To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.
Investigators attempted to reach international agreement on the definition of textbook outcome in liver surgery and to assess occurrence of this outcome following liver resection.